Truist Financial
IRWD icon

Truist Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Truist Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-35,529
Closed -$150K – 2947
2026
Q2 		$150K Buy
+35,529
New +$137K ﹤0.01% 2821

Other funds holding IRWD

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
O'Shaughnessy Asset Management
O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Truist Financial's IRWD Position: Q3 2026 in Review

Truist Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2026, closing a stake of 35,529 shares — an estimated $150K sold.

Truist Financial first reported a position in IRWD in Q2 2026 and held it in 1 quarter. The position peaked at $150K in Q2 2026. 143 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Truist Financial reported no remaining Ironwood Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Truist Financial sold 35,529 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $150K.
  • Truist Financial first reported a position in Ironwood Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Truist Financial's Ironwood Pharmaceuticals position peaked at $150K in Q2 2026.
  • 143 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.